PHARMAC is notifying the
tender award for the supply of
some amoxicillin presentations
earlier than the usual end of
month notification to make sure
all interested parties are aware as
soon as possible.
MEANWHILE PHARMAC has
also said it will fund febuxostat
(Adenuric) from 01 Jun for the
treatment of patients with severe
gout.
Several gout treatments are
already funded by PHARMAC but
the clinical advisory committee
identified a need for additional
treatment, it said.The above article was sent to subscribers in Pharmacy Daily's issue from 22 May 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 May 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.